SPOK
Spok Holdings, Inc
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$12.16
+1.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 135.1M | 139.7M | 137.7M | 139.0M | 134.5M |
| Cost of Revenue | 15.5M | 29.6M | 28.4M | 57.2M | 59.3M |
| Gross Profit | 119.6M | 110.1M | 109.2M | 81.9M | 75.3M |
| Operating Expenses | |||||
| R&D Expense | 13.0M | 12.1M | 11.5M | 10.5M | 13.6M |
| SG&A Expense | 45.7M | 50.9M | 49.2M | 49.5M | 54.1M |
| General & Admin Expense | 29.9M | 33.4M | 33.3M | — | — |
| Selling & Marketing Expense | 15.9M | 17.5M | 15.9M | — | — |
| Other Expenses | 41.7M | 27.5M | 29.6M | — | — |
| Total Operating Expenses | 100.4M | 90.4M | 90.3M | 60.1M | 67.7M |
| Cost and Expenses | 115.9M | 120.0M | 118.7M | 117.2M | 127.0M |
| Operating Income (EBIT) | 19.2M | 19.7M | 19.0M | 21.8M | 7.6M |
| Non-Operating | |||||
| Interest Income | 719.0K | 820.0K | 1.2M | 1.1M | 592.0K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 719.0K | 820.0K | 1.2M | 1.1M | 592.0K |
| Other Non-Op Income/Expense | 6.6M | 1.7M | 1.1M | 524.0K | (6.6M) |
| Non-Operating Income (excl Interest) | (8.1M) | (1.7M) | (1.1M) | (524.0K) | 6.6M |
| EBT (Pre-Tax Income) | 25.8M | 21.4M | 20.0M | 22.3M | 997.0K |
| Income Tax Expense | 7.1M | 5.6M | 5.1M | 6.7M | (20.9M) |
| Bottom Line | |||||
| Net Income | 18.8M | 15.9M | 15.0M | 15.7M | 21.9M |
| Earnings from Cont. Ops | 18.8M | 15.9M | 15.0M | 15.7M | 21.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 18.8M | 15.9M | 15.0M | 15.7M | 21.9M |
| Per Share | |||||
| Basic EPS | $0.90 | $0.77 | $0.74 | $0.79 | $1.11 |
| Diluted EPS | $0.89 | $0.75 | $0.73 | $0.77 | $1.09 |
| Revenue Per Share | $6.46 | $6.78 | $6.80 | $6.97 | $6.84 |
| Shares | |||||
| Basic Shares Outstanding | 20.9M | 20.6M | 20.2M | 20.0M | 19.7M |
| Diluted Shares Outstanding | 21.2M | 21.1M | 20.6M | 20.3M | 20.0M |
| Profitability Metrics | |||||
| EBITDA | 31.0M | 24.9M | 24.2M | 26.8M | 4.6M |
| D&A | 3.7M | 3.4M | 4.1M | 4.5M | 3.6M |
| EBIT | 27.3M | 21.4M | 20.1M | 22.3M | 997.0K |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026